Harbour BioMed (2142.HK,HBMHF), a biopharmaceutical company, on Thursday announced the appointment of Adam Zong as its new President.
Zong brings more than 20 years of global biopharma leadership experience.
Zong joins from Arc Nouvel Clinical Development Consulting where he served as Principal Consultant
On the Hongkong Stock Exchange, shares of Harbour closed Thursday's regular trading 2.14 percent higher at HK$14.790
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.